Continence 40 mg/ml Syrup for Dogs

Држава: Велика Британија

Језик: Енглески

Извор: VMD (Veterinary Medicines Directorate)

Активни састојак:

Phenylpropanolamine

Доступно од:

Fatro S.p.A.

АТЦ код:

QG04BX91

INN (Међународно име):

Phenylpropanolamine

Фармацеутски облик:

Syrup

Тип рецептора:

POM-V - Prescription Only Medicine – Veterinarian

Терапеутска група:

Dogs

Терапеутска област:

Neurological Agent

Статус ауторизације:

Authorized

Датум одобрења:

2019-08-09

Карактеристике производа

Unlimited renewal: August 2023
AN: 01200/2023
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
CONTINENCE 40 mg/ml syrup for dogs
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
1 ml contains:
ACTIVE SUBSTANCE:
Phenylpropanolamine………………………………………40.28
mg
equivalent to phenylpropanolamine hydrochloride………...50 mg
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Syrup.
Clear colourless to pale yellow solution.
4.
CLINICAL PARTICULARS
4.1.
TARGET SPECIES
Dogs
4.2.
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the management of urinary incontinence associated with urethral
sphincter
incompetence in the bitch, particularly that associated with
ovariohysterectomy.
4.3.
CONTRAINDICATIONS
Do
not
administer
to
patients
treated
with
non-selective
monoamine
oxidase
inhibitors.
Do not use in cases of known hypersensitivity to the active substance
or to any of
the excipients.
Do not administer to pregnant or lactating bitches.
4.4.
SPECIAL WARNINGS FOR EACH TARGET SPECIES
The product should be avoided in hypertensive individuals.
In bitches less than 1 year old the possibility of anatomical
disorders contributing to
incontinence should be considered prior to treatment.
The use of the product is not appropriate for the treatment of
behavioural causes of
inappropriate urination.
Unlimited renewal: August 2023
AN: 01200/2023
Page 2 of 5
4.5.
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Phenylpropanolamine, a sympathomimetic drug, may affect the
cardiovascular
system, especially blood pressure and heart rate, and should be used
with caution in
animals with cardiovascular diseases.
Care
should
be
exercised
in
treating
animals
with
severe
renal
or
hepatic
insufficiency, diabetes mellitus, hyperadrenocorticism, glaucoma,
hyperthyroidism or
other metabolic disorders.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
Phenylpropanolamine hydrochloride is to